COMMUNIQUÉS West-GlobeNewswire

Vystar Receives Second European Patent for Reduced Allergenicity Natural Rubber Latex
04/03/2019
Vystar’s Vytex® deproteinization method reduces allergenicity and odor, Manufacturing process uses less water, chemical and dyes for naturally, purer, whiter and stronger latex WORCESTER, Mass., March 04, 2019 (GLOBE [...]
Novo Nordisk A/S - Share repurchase programme
04/03/2019
Bagsværd, Denmark, 4 March 2019 - On 1 February 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Microbot Medical Announces Notice of Intention to Grant of European Patent for Adjustable Guidewire Technology
04/03/2019
HINGHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Further expanding its global IP portfolio, Microbot Medical Inc. (Nasdaq CM: MBOT) received an official communication from the European Patent Office regarding its [...]
Avid Bioservices To Report Financial Results For Third Quarter Of Fiscal Year 2019 After Market Close On March 11, 2019
04/03/2019
TUSTIN, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
MyoKardia Announces Positive Six-Month Safety and Efficacy Data from PIONEER-OLE Study of Mavacamten for the Treatment of Symptomatic, Obstructive HCM
04/03/2019
Mavacamten Well Tolerated; Results Show Statistically Significant Elimination of Obstruction and Durable NYHA Class Improvements Statistically Significant Improvement in Several Key Biomarkers Suggest Potential for [...]
EDAP TMS SA : HIFU Pioneer Houston Methodist Hospital Acquires EDAP's Next Generation Focal One HIFU System
04/03/2019
Houston Methodist's Upgrade from Ablatherm to Focal One Reinforces EDAP's Position as a Leading HIFU Innovator LYON, France, March 4, 2019 -- EDAP TMS SA (Nasdaq: EDAP) -- Houston Methodist Hospital, one of the first [...]
Saint Anthony Hospital expands Allscripts partnership to enable clinical data integration between ambulatory and acute settings
04/03/2019
Hospital extends and further expands portfolio to provide single clinical and financial record CHICAGO, March 04, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) announced today that Saint Anthony Hospital has signed [...]
RedHill Biopharma Announces New European and Japanese Patents for Talicia®
04/03/2019
The European and Japanese patent applications have been accepted and, once granted, are expected to be valid until 2034 U.S. NDA for Talicia ® on track for potential submission in H1/2019 and U.S. commercial launch in [...]
Ovid Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference on Monday, March 11
04/03/2019
NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]
Misonix Names Sharon Klugewicz Chief Operating Officer
04/03/2019
Proven C-Suite Executive Brings Extensive Healthcare Industry Experience to New Role FARMINGDALE, N.Y., March 04, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of [...]
Rexahn Announces Target Enrollment Reached in Phase 2a Clinical Trial of RX-3117 in Combination With ABRAXANE® in First-line Metastatic Pancreatic Cancer Patients
04/03/2019
Expected Study Completion in Second Half 2019 ROCKVILLE, Md., March 04, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company developing innovative [...]
The Joint Corp. to Present at the 31st Annual ROTH Conference
04/03/2019
To offer free chiropractic adjustments March 17 through March 19 SCOTTSDALE, Ariz., March 04, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics [...]
Neon Therapeutics to Present at Cowen and Company 39th Annual Health Care Conference
04/03/2019
CAMBRIDGE, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that Hugh O’Dowd, Chief [...]
Immunomedics to Participate in Cowen and Company 39th Annual Health Care Conference
04/03/2019
MORRIS PLAINS, N.J., March 04, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
Chimerix to Present at Cowen and Company 39th Annual Health Care Conference
04/03/2019
DURHAM, N.C., March 04, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that Timothy Trost, Chief [...]
Jounce Therapeutics to Present at Cowen and Company 39th Annual Health Care Conference
04/03/2019
CAMBRIDGE, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]
Immutep to Present at Oppenheimer’s 29th Annual Healthcare Conference
04/03/2019
SYDNEY, Australia, March 04, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
AnaptysBio to Present at the Cowen and Company 39th Annual Health Care Conference
04/03/2019
SAN DIEGO, March 04, 2019 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation [...]
Tetra Bio-Pharma and Santé Cannabis Announce Completion of the First Phase 2 Cannabis Oil Trial in Cancer and Non-Cancer Patients
04/03/2019
OTTAWA, March 04, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX-V: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-derived drug development and discovery, is pleased to announce [...]

Pages